M&A Deal Summary

Hologic Acquires Sentinelle Medical

On August 5, 2010, Hologic acquired medical products company Sentinelle Medical for 85M USD

Acquisition Highlights
  • This is Hologic’s 9th transaction in the Medical Products sector.
  • This is Hologic’s 15th largest (disclosed) transaction.
  • This is Hologic’s 1st transaction in Canada.
  • This is Hologic’s 1st transaction in Ontario.

M&A Deal Summary
Date 2010-08-05
Target Sentinelle Medical
Sector Medical Products
Buyer(s) Hologic
Deal Type Add-on Acquisition
Deal Value 85M USD

Target

Sentinelle Medical

Toronto, Ontario, Canada
Sentinelle Medical, Inc. is a provider of Magnetic Resonance Imaging (MRI) breast coils, tables and visualization software. Company is dedicated to improving patient care with early detection and accurate intervention.

Search 193,381 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Hologic

Marlborough, Massachusetts, United States

website

Category Company
Founded 1985
Sector Medical Products
Employees6,944
Revenue 4.9B USD (2022)
DESCRIPTION
Hologic's corporate headquarters in Marlborough, Massachusetts.
Hologic's corporate headquarters in Marlborough, Massachusetts.

Hologic is a developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women throughout the world. Hologic was formed in 1985 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 10 of 24
Sector (Medical Products) 9 of 18
Type (Add-on Acquisition) 9 of 22
State (Ontario) 1 of 1
Country (Canada) 1 of 1
Year (2010) 1 of 1
Size (of disclosed) 15 of 23
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-06-09 Third Wave Technologies

Madison, Wisconsin, United States

Third Wave Technologies, Inc. is a developer and marketer of molecular diagnostic reagents for a wide variety of DNA and RNA analysis applications based on its proprietary Invader chemistry. The company's current clinical diagnostic offerings consist of products for conditions such as Cystic Fibrosis, Hepatitis C, cardiovascular risk and other diseases.

Buy $580M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-01-07 Interlace Medical

Framingham, Massachusetts, United States

Interlace Medical, Inc., is a developer and manufacturer of the MyoSure hysteroscopic tissue removal system (MyoSure).

Buy $125M
Mergr

Product

Company

Legal